HomeContact

Fidia Advanced Biomaterials


Development of breakthrough technology in the field of human tissue regeneration, from skin and cartilage to neuronal tissue, for the treatment of severe pathologies.


FIDIA is a pharmaceutical company founded in Bologna, Italy, in 1946 with major activities in the field of orthopaedics, traumatology, rheumatology and tissue repair. In 1963, the company launched its first proprietary product based on hyaluronic acid (hyaluronan), a polysaccharide which is present in many human tissues, for the treatment of skin burns and cutaneous ulcers. The company has four subsidiaries. The activities of the Fidia Group are mainly devoted to the Osteo-Articular, Tissue Repair, Ophthalmology and Neuroscience fields of business.

Fidia is the coordinator of regenerative medicine section of the “European Technology Plantform on Nanocmedicine”


Lanfranco Callegaro, CEO
Michael O’Regan, Marketing Director


Via ponte della Fabbrica 3/A
35031 Abano Terme, Padova
Italy
Phone: +39-49-823-2111
Fax: +39-49-810-653


HYALOGRAFT® C: cartilage substitute made of autologous chondrocytes delivered on a biocompatible tridimensional materix that is composed of a derivative of hyaluronic acid (HYAFF®).

The company has filed numerous patents. A selection of patents is listed below. Please refer to the American Patent and Trademark Office or Esp@cenet for comprehensive information on the company’s patent portfolio.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.

Related patents